LIM
RPRX icon

Lagoda Investment Management’s Royalty Pharma RPRX Stock Holding History

Lagoda Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,930
Closed -$1.06M – 40
2023
Q3 		$1.06M Sell
38,930
-18,250
-32% -$542K 0.69% 19
2023
Q2 		$1.76M Sell
57,180
-44,320
-44% -$1.5M 1.24% 17
2023
Q1 		$3.66M Sell
101,500
-17,580
-15% -$652K 2.6% 16
2022
Q4 		$4.71M Sell
119,080
-22,225
-16% -$928K 3.18% 14
2022
Q3 		$5.68M Buy
141,305
+4,670
+3% +$199K 4.04% 13
2022
Q2 		$5.74M Sell
136,635
-4,925
-3% -$202K 3.81% 13
2022
Q1 		$5.51M Buy
141,560
+1,125
+0.8% +$44.2K 2.97% 14
2021
Q4 		$5.6M Buy
140,435
+18,950
+16% +$736K 2.65% 16
2021
Q3 		$4.39M Buy
121,485
+11,680
+11% +$454K 2.19% 17
2021
Q2 		$4.5M Buy
109,805
+4,970
+5% +$211K 2.1% 17
2021
Q1 		$4.57M Buy
104,835
+7,950
+8% +$377K 2.28% 16
2020
Q4 		$4.85M Buy
96,885
+44,648
+85% +$1.89M 2.61% 16
2020
Q3 		$2.2M Buy
+52,237
New +$2.24M 1.63% 16

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lagoda Investment Management's RPRX Position: Q4 2023 in Review

Lagoda Investment Management sold out of Royalty Pharma (RPRX) in Q4 2023, closing a stake of 38,930 shares — an estimated $1.06M sold.

Lagoda Investment Management first reported a position in RPRX in Q3 2020 and held it in 13 quarters. The position peaked at $5.74M in Q2 2022. 363 funds tracked by Wall St. Rank hold RPRX as of Q4 2023.

  • Lagoda Investment Management reported no remaining Royalty Pharma position as of Q4 2023 after selling out during the quarter.
  • Lagoda Investment Management sold 38,930 Royalty Pharma shares in Q4 2023, an estimated $1.06M.
  • Lagoda Investment Management first reported a position in Royalty Pharma in Q3 2020 and held it in 13 quarters.
  • Lagoda Investment Management's Royalty Pharma position peaked at $5.74M in Q2 2022.
  • 363 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2023.

Based on Lagoda Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.